Patients
shock
SHOCK
Patients enrolled in ATHOS-3 were ≥ 18 years of age with vasodilatory shock, MAP of 55–70 mmHg, despite adequate volume resuscitation and receipt of vasopressors at a dose > 0.2 µg/kg/min NED for 6–48 h prior to enrollment; background vasopressor use was not standardized and included catecholamines and vasopressin based on regional availability.